The quorum sensing (QS) system in multi-drug-resistant bacteria such as is primarily responsible for the development of antibiotic resistance and is considered an attractive target for antimicrobial drug discovery. In this study, we synthesised a series of novel selenourea and thiourea-containing dihydropyrrol-2-one (DHP) analogues as LasR antagonists. The selenium DHP derivatives displayed significantly better quorum-sensing inhibition (QSI) activities than the corresponding sulphur analogues. The most potent analogue efficiently inhibited the QS system by 81% at 125 µM and 53% at 31 µM. Additionally, all the compounds were screened for their minimum inhibitory concentration (MIC) against the Gram-positive bacterium , and interestingly, only the selenium analogues showed antibacterial activity, with and being the most potent with a MIC of 15.6 µM.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003518PMC
http://dx.doi.org/10.3390/antibiotics10030321DOI Listing

Publication Analysis

Top Keywords

analogues antibacterial
8
novel seleno-
4
seleno- thio-urea
4
thio-urea dihydropyrrol-2-one
4
analogues
4
dihydropyrrol-2-one analogues
4
antibacterial agents
4
agents quorum
4
quorum sensing
4
sensing system
4

Similar Publications

Three new terpenoid derivatives from the deep-sea-derived fungus DFFSCS007.

J Asian Nat Prod Res

December 2024

CAS Key Laboratory of Tropical Marine Bio-resources and Ecology, Guangdong Key Laboratory of Marine Materia Medica, South China Sea Institute of Oceanology, Chinese Academy of Sciences, Guangzhou 510301, China.

Three new terpenoid derivatives (1,6,7)-hydrobenzosydowic acid (), (1 ,6,7)-hydrobenzosydowic acid (), and (7 ,10)-11-dehydroxy-iso-10-hydroxysydowic acid (), along with the known analogues ()-2-(1-(4-nitrobenzoyl)pyrrolidine-2-carboxamido)benzoic acid () and trihydroxybutyl ester of 4-carboxydiorcinol () were isolated from the deep-sea-derived fungus DFFSCS007. Their structures were determined by spectroscopic analysis. Compound with a nitrobenzene group was isolated from nature for the first time.

View Article and Find Full Text PDF

PTGES3 proteolysis using the liposomal peptide-PROTAC approach.

Biol Direct

December 2024

Center of Hepatobiliary Pancreatic Disease, Xuzhou Central Hospital, Xuzhou, Jiangsu, 221009, China.

Background: Hepatocellular carcinoma (HCC) is the leading cause of cancer-related deaths worldwide, and the lack of effective biomarkers for early detection leads to poor therapeutic outcomes. Prostaglandin E Synthase 3 (PTGES3) is a putative prognostic marker in many solid tumors; however, its expression and biological functions in HCC have not been determined. The proteolysis-targeting chimera (PROTAC) is an established technology for targeted protein degradation.

View Article and Find Full Text PDF

Green tea has garnered increasing attention across age groups due to its numerous health benefits, largely attributed to Epigallocatechin 3-gallate (EGCG), its key polyphenol. EGCG exhibits a wide spectrum of biological activities, including antioxidant, anti-inflammatory, antibacterial, anticancer, and neuroprotective properties, as well as benefits for cardiovascular and oral health. This review provides a comprehensive overview of recent findings on the therapeutic potential of EGCG in various human diseases.

View Article and Find Full Text PDF

Autophagy is a lysosome-dependent cellular degradation pathway that responds to a variety of environmental and cellular stresses, which is defective in aging and age-related diseases, therefore, targeting autophagy with small-molecule activators has potential therapeutic benefits. In this study, we successfully completed the first total synthesis of Ivesinol, an identified antibacterial natural product, and efficiently constructed a library of its analogs. To measure the effect of Ivesinol analogs on autophagic activity, we performed cell imaging-based screening approach, and observed that several Ivesinol analogs exhibited potent autophagy-regulating activity.

View Article and Find Full Text PDF

This report explores the potential of novel 6-aryloxy-2-aminopyrimidine-benzonitrile scaffolds as promising anti-infective agents in the face of the increasing threat of infectious diseases. Starting from 2-amino-4,6-dichloropyrimidine, a series of 24 compounds inspired from the antiviral drugs dapivirine, etravirine, and rilpivirine were designed and synthesized via a two-step reaction sequence in good yields. Biological testing of synthetic analogs revealed potent inhibition against both viral and tuberculosis targets.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!